GLP-1 Focused Yazen Expands to Denmark with Acquisition of Medstart
Malmö-based digital healthcare provider Yazen, focusing on obesity treatment, has announced the acquisition of Danish healthcare company Medstart. The move marks Yazen’s entry into the Danish market and strengthens its presence in Norway, furthering its goal to become a leading player in obesity care across Europe. Shared Approach to Obesity Care Medstart, established in Denmark […]
Yazen Secures Over €19M to Fuel Global Expansion Amid Ozempic Wave
Yazen, a digital healthcare provider based in Lund, has successfully closed a Series A funding round of € 19.5 million (226 million SEK). This investment comes as Yazen continues to ride the growing wave of interest in GLP-1 drug Ozempic, a medication primarily used for weight management. The round, led by Evli Growth Partners and […]